A study to evaluate the concurrent cetuximab versus platinum-based chemoradiation in patients with locoregionally advanced head and neck cancer.

Trial Profile

A study to evaluate the concurrent cetuximab versus platinum-based chemoradiation in patients with locoregionally advanced head and neck cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Cetuximab (Primary)
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Acronyms SOCCER
  • Most Recent Events

    • 11 Oct 2016 Interim results from non-selected patient cohort presented at the 41st European Society for Medical Oncology Congress.
    • 28 Sep 2016 According to the Merck and Co. media release, the company will present data of an interim analysis from non-selected patient cohort of this trial at the European Society for Medical Oncology (ESMO) annual meeting.
    • 11 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top